These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29253125)

  • 1. Improving the quality of point-of-care testing.
    Price CP; Smith I; Van den Bruel A
    Fam Pract; 2018 Jul; 35(4):358-364. PubMed ID: 29253125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical performance specifications and quality assurance of point-of-care testing in primary healthcare.
    Stavelin A; Sandberg S
    Crit Rev Clin Lab Sci; 2024 May; 61(3):164-177. PubMed ID: 37779370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Internal Quality Control and External Quality Assessment on POCT].
    Kuwa K
    Rinsho Byori; 2015 Feb; 63(2):224-31. PubMed ID: 26529974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality assuring HIV point of care testing using whole blood samples.
    Dare-Smith R; Badrick T; Cunningham P; Kesson A; Badman S
    Pathology; 2016 Aug; 48(5):498-500. PubMed ID: 27306578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External quality assessment schemes for glucose measurements in Germany: factors for successful participation, analytical performance and medical impact.
    Bietenbeck A; Geilenkeuser WJ; Klawonn F; Spannagl M; Nauck M; Petersmann A; Thaler MA; Winter C; Luppa PB
    Clin Chem Lab Med; 2018 Jul; 56(8):1238-1250. PubMed ID: 29708877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Point-of-care testing in primary healthcare: a scoring system to determine the frequency of performing internal quality control.
    Gidske G; Sandberg S; Fossum AL; Binder S; Langsjøen EC; Solsvik AE; Stavelin A
    Clin Chem Lab Med; 2022 Apr; 60(5):740-747. PubMed ID: 35150123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point-of-care testing governance in New Zealand through the lens of quality: an update on a national regulatory framework.
    Musaad SM; Herd GC
    N Z Med J; 2019 Jul; 132(1499):56-63. PubMed ID: 31352475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of an Aboriginal community-based renal disease management program incorporating point of care testing for urine albumin:creatinine ratio.
    Shephard MD; Allen GG; Paizis K; Barbara JA; Batterham M; Vanajek A
    Rural Remote Health; 2006; 6(4):591. PubMed ID: 17022724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point-of-care testing (POCT) and evidence-based laboratory medicine (EBLM) - does it leverage any advantage in clinical decision making?
    Florkowski C; Don-Wauchope A; Gimenez N; Rodriguez-Capote K; Wils J; Zemlin A
    Crit Rev Clin Lab Sci; 2017; 54(7-8):471-494. PubMed ID: 29169287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bridging the gap between point-of-care testing and laboratory testing in hemostasis.
    Kitchen DP; Jennings I; Kitchen S; Woods TA; Walker ID
    Semin Thromb Hemost; 2015 Apr; 41(3):272-8. PubMed ID: 25775047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers to hospital-based clinical adoption of point-of-care testing (POCT): A systematic narrative review.
    Quinn AD; Dixon D; Meenan BJ
    Crit Rev Clin Lab Sci; 2016; 53(1):1-12. PubMed ID: 26292075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Participating in a Quality Improvement System over Time for Point-of-Care C-Reactive Protein, Glucose, and Hemoglobin Testing.
    Bukve T; Stavelin A; Sandberg S
    Clin Chem; 2016 Nov; 62(11):1474-1481. PubMed ID: 27591289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The state of point-of-care testing: a European perspective.
    Larsson A; Greig-Pylypczuk R; Huisman A
    Ups J Med Sci; 2015 Mar; 120(1):1-10. PubMed ID: 25622619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community paramedic point of care testing: validity and usability of two commercially available devices.
    Blanchard IE; Kozicky R; Dalgarno D; Simms J; Goulder S; Williamson TS; Biesbroek S; Page L; Leaman K; Snozyk S; Redman L; Spackman K; Doig CJ; Lang ES; Lazarenko G
    BMC Emerg Med; 2019 May; 19(1):30. PubMed ID: 31046680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assuring quality in point-of-care testing: evolution of technologies, informatics, and program management.
    Lewandrowski K; Gregory K; Macmillan D
    Arch Pathol Lab Med; 2011 Nov; 135(11):1405-14. PubMed ID: 22032566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of glucose point of care testing in three metropolitan hospitals.
    Sharp L; Farrance I; Greaves RF
    Pathology; 2016 Jan; 48(1):51-9. PubMed ID: 27020210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical performance specifications for external quality assessment - definitions and descriptions.
    Jones GRD; Albarede S; Kesseler D; MacKenzie F; Mammen J; Pedersen M; Stavelin A; Thelen M; Thomas A; Twomey PJ; Ventura E; Panteghini M;
    Clin Chem Lab Med; 2017 Jun; 55(7):949-955. PubMed ID: 28593915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Users Regard Operator Training as Critical for Successful POCT Applications.
    Bietenbeck A; Wüst K; Luppa PB
    Clin Lab; 2020 Jan; 66(1):. PubMed ID: 32013370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential aspects of external quality assurance for point-of-care testing.
    Stavelin A; Sandberg S
    Biochem Med (Zagreb); 2017 Feb; 27(1):81-85. PubMed ID: 28392729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards harmonization of external quality assessment/proficiency testing in hemostasis.
    Favaloro EJ; Jennings I; Olson J; Van Cott EM; Bonar R; Gosselin R; Meijer P
    Clin Chem Lab Med; 2018 Dec; 57(1):115-126. PubMed ID: 29668440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.